Expression of glyoxalase I and II in normal and breast cancer tissues

By Rulli A.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 1, 2001-03 ,pp. : 67-72

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome proliferatoractivated receptor γ2 Pro12Ala (rs1801282) polymorphism and breast cancer susceptibility: A metaanalysis

By          

Molecular Medicine Reports, Vol. 8, Iss. 6, 2013-01 ,pp. : 1773-1778

Spandidos Publications

Access to resources Recommend Favorite

A possible regulatory role of 17β-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells

By Rulli Antonio   Antognelli Cinzia   Prezzi Eleonora   Baldracchini Francesca   Piva Francesco   Giovannini Elvio   Talesa Vincenzo  

Breast Cancer Research and Treatment, Vol. 96, Iss. 2, 2006-03 ,pp. : 187-196

Springer Publishing Company

Access to resources Recommend Favorite

Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects

By Qiu Li-Xin  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 543-547

Springer Publishing Company

Access to resources Recommend Favorite

No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls

By Ma Xiangyu  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 509-514

Springer Publishing Company

Access to resources Recommend Favorite